Dr Erica D Mcarn, PHD - Medicare Psychologist in Riverbank, CA

Dr Erica D Mcarn, PHD is a medicare enrolled "Psychologist - Clinical" provider in Riverbank, California. Her current practice location is 2603 Patterson Rd Ste 7, Riverbank, California. You can reach out to her office (for appointments etc.) via phone at (775) 304-7510.

Dr Erica D Mcarn is licensed to practice in California (license number PSY32034) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1457895021.

Contact Information

Dr Erica D Mcarn, PHD
2603 Patterson Rd Ste 7,
Riverbank, CA 95367-3407
(775) 304-7510
Not Available



Healthcare Provider's Profile

Full NameDr Erica D Mcarn
GenderFemale
SpecialityPsychologist - Clinical
Location2603 Patterson Rd Ste 7, Riverbank, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1457895021
  • Provider Enumeration Date: 12/15/2016
  • Last Update Date: 04/25/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3779992128
  • Enrollment ID: I20210616000912

Medical Identifiers

Medical identifiers for Dr Erica D Mcarn such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457895021NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist (* (Not Available))Secondary
103TC0700XPsychologist - Clinical PSY32034 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Erica D Mcarn allows following entities to bill medicare on her behalf.
Entity NameHumanizing Healing Psychological Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124606595
PECOS PAC ID: 2062821416
Enrollment ID: O20210514001283

News Archive

Researchers study biological risk potential of nanoparticles

Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.

FDA approves novel genetic test for patients with breast cancer

The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels

Researchers unravel control of growing blood vessels

Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.

Read more Medical News

› Verified 6 days ago

Entity NameGrow Healthcare Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154994846
PECOS PAC ID: 1850774746
Enrollment ID: O20220809004080

News Archive

Researchers study biological risk potential of nanoparticles

Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.

FDA approves novel genetic test for patients with breast cancer

The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels

Researchers unravel control of growing blood vessels

Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Erica D Mcarn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Erica D Mcarn, PHD
2603 Patterson Rd Ste 7,
Riverbank, CA 95367-3407

Ph: () -
Dr Erica D Mcarn, PHD
2603 Patterson Rd Ste 7,
Riverbank, CA 95367-3407

Ph: (775) 304-7510

News Archive

Researchers study biological risk potential of nanoparticles

Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.

FDA approves novel genetic test for patients with breast cancer

The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).

Study assesses cardiovascular and renal outcomes for ertugliflozin in patients with type 2 diabetes

A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels

Researchers unravel control of growing blood vessels

Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.

Read more News

› Verified 6 days ago


Psychologist in Riverbank, CA


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.